Peter Barrett
Chairman at SYNLOGIC, INC.
Net worth: 2 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Prahlad Singh | M | 59 | 10 years | |
| Antoine Awad | M | 44 | 6 years | |
| Richard Shea | M | 72 | 21 years | |
| Mary Dooley | F | 43 | 6 years | |
| Michael Celano | M | 65 | 4 years | |
| Joel Goldberg | M | 55 | 16 years | |
| Michael Heffernan | M | 59 |
Indalo Therapeutics, Inc.
 Indalo Therapeutics, Inc. BiotechnologyHealth Technology Indalo Therapeutics, Inc. operates as a biopharmaceutical firm that develops integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). The company was founded by David Griggs, Williamson Z. Bradford III, Peter Ruminski, and Robert W. Karr and is headquartered in Cambridge, MA. | 5 years |
| Alexis Michas | M | 66 | 23 years | |
| Ommer Chohan | M | - |
Atlas Venture Life Science Advisors LLC
 Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 9 years |
| Samuel Chapin | M | 66 | 8 years | |
| Michel Vounatsos | M | 62 | 4 years | |
| Nick Leschly | M | 51 | 7 years | |
| Michael Gladstone | M | 37 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 9 years |
| Thomas J. Adam | M | - | 7 years | |
| Jodie Morrison | F | 48 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 3 years |
| Bryan A. Kipp | M | - | - | |
| Thomas Hamilton | M | 56 | 4 years | |
| Bruce Booth | M | 49 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 10 years |
| Jason Rhodes | M | 54 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 10 years |
| Michelle McMurry-Heath | M | 54 | 2 years | |
| Joseph Truitt | M | 59 | 4 years | |
| Maria Fardis | M | 56 |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | 3 years |
| Kevin Bitterman | M | 47 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 7 years |
| Pascale Witz | F | 57 | 7 years | |
| Tajinder Vohra | M | 58 | 9 years | |
| Jonathan Leff | M | 55 | 4 years | |
| Michael Gilman | M | 69 |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | 8 years |
| Ed Mathers Mathers | M | 64 | 12 years | |
| Yi Ping Lin | F | - | 1 years | |
| Jean-Francois Formela | M | 67 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 10 years |
| Frank Thomas | M | 54 | 4 years | |
| Maxwell Krakowiak | M | 35 | 6 years | |
| Brendan St Amant | M | - | 3 years | |
| Frank R. Witney Witney | M | 70 | 8 years | |
| Dave Grayzel | M | 56 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 10 years |
| Caroline Kurtz | M | - | 8 years | |
| Daniel Tereau | M | 55 | 10 years | |
| Anita Elberse | M | 51 |
Harvard Business School
| - |
| Madhuri Hegde | M | - | 1 years | |
| Robert Ross | M | 50 |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | 4 years |
| David Scharfstein | M | 63 |
Harvard Business School
| 21 years |
| Fara Goldberg | F | - | - | |
| Chris Klebanoff | M | - |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | - |
| Xiangyu Ouyang | M | - |
JenaValve Technology GmbH
 JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | - |
| Anderson Timothy | M | - |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | - |
| Michael Klobuchar | M | 48 | - | |
| Jayashree Kailas Thacker | F | - | 1 years | |
| Miriame Victor | F | 43 | 1 years | |
| Shikhar Ghosh | M | 66 |
Harvard Business School
| 16 years |
| Xiang Yu Ou Yang | M | - |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | - |
| Shashank Singh | M | 47 |
Harvard Business School
| - |
| Erik Amble | M | 72 |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | - |
| Joshua Harris | M | 59 |
Harvard Business School
| - |
| Patrick van Beneden | M | 62 |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | 14 years |
| William Kirby | M | 72 |
Harvard Business School
| 16 years |
| Lynn Sharp Paine | M | 74 |
Harvard Business School
| 14 years |
| J. Cline | M | 64 |
Harvard Business School
| - |
| Mark McDade | M | 69 |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | - |
| Juan Arena de la Mora | M | 80 |
Harvard Business School
| - |
| Douglas Grissom | M | 56 |
Harvard Business School
| - |
| Markus Miele | M | 56 |
Harvard Business School
| - |
| Carl Christian Gilhuus-Moe | M | 80 |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | - |
| Ankit Mahadevia | M | 43 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | - |
| Steve Willoughby | M | - | 3 years | |
| Johannes Keltjens | M | 67 |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | - |
| Olivier Litzka | M | 56 |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | - |
| Franz Hefti | M | 76 |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | - |
| Hirotaka Takeuchi | M | 77 |
Harvard Business School
| 48 years |
| Philip Bilden | M | 59 |
Harvard Business School
| - |
| James Cash | M | 75 |
Harvard Business School
| 48 years |
| Jo-Ann Beltramello | F | - | 17 years | |
| Claus Asbjørn Andersson | M | 56 |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | - |
| Robert Woodman | M | 46 |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | 5 years |
| Anita Gonzales | F | 48 | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Friel | M | 68 | 20 years | |
| Craig Wheeler | M | 63 | 14 years | |
| Aoife Brennan | M | 48 | 8 years | |
| Hong Zhao | M | 60 | - | |
| Jeffrey Moore | M | 63 | 5 years | |
| Stanley Lapidus | M | 75 | 8 years | |
| Noubar Afeyan | M | 60 | 9 years | |
| Andrew Okun | M | 54 | 22 years | |
| Todd Shegog | M | 59 | 3 years | |
| Stephen J. Lombardi | M | 68 | 4 years | |
| John Duncan Higgons | M | 69 |
Archemix Corp.
 Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | 3 years |
| Jose-Carlos Gutiérrez-Ramos | M | 61 | 3 years | |
| Ronald Lowy | M | 68 | - | |
| Christoph H. Westphal | M | 56 | 5 years | |
| Stephen Hall | M | 73 | 1 years | |
| Ken Bate | M | 73 |
Archemix Corp.
Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | 3 years |
| David Epstein | M | 65 |
Archemix Corp.
Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | 2 years |
| Riccardo Pigliucci | M | 77 |
Perkin Elmer Corp.
 Perkin Elmer Corp. BiotechnologyHealth Technology Perkin Elmer Corp. provides solutions for diagnostics, life sciences, food, and applied markets. The private company is based in Norwalk. The American company's accurate and robust instrumentation and sample handling technologies support the work of regulatory bodies and industry scientists in PPCPs analysis. The company's life sciences products include detection and imaging systems, assays and reagents, automation solutions, informatics platforms, and services. | 3 years |
| Ira D. Lawrence | M | 71 | 8 years | |
| Errol de Souza | M | 70 |
Archemix Corp.
Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | 6 years |
| Kenton Sicchitano | M | 79 | 16 years | |
| Vicki Sato | M | 75 | 16 years | |
| Patrick Sullivan | M | 72 | 12 years | |
| Elizabeth Stoner | M | 73 | 13 years | |
| Daniel Marshak | M | 67 | 8 years | |
| Nicholas A. Lopardo | M | 77 | 23 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 92 | 92.00% |
| Germany | 8 | 8.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Peter Barrett
- Personal Network